Your browser doesn't support javascript.
loading
PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.
Roberts, Rebecca L; Wallace, Mary C; Seinen, Margien L; Krishnaprasad, Krupa; Chew, Angela; Lawrance, Ian; Prosser, Ruth; Bampton, Peter; Grafton, Rachel; Simms, Lisa; Studd, Corrie; Bell, Sally J; Radford-Smith, Graham; Andrews, Jane M; Barclay, Murray L.
Afiliação
  • Roberts RL; 1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Wallace MC; 1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Seinen ML; Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
  • Krishnaprasad K; 1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Chew A; 1] Centre for Inflammatory Bowel Disease, Fremantle Hospital, Fremantle, Western Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Lawrance I; 1] Centre for Inflammatory Bowel Disease, Fremantle Hospital, Fremantle, Western Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Prosser R; 1] Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Bampton P; 1] Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Grafton R; 1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Simms L; 1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Radford-Smith G; 1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Andrews JM; 1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
  • Barclay ML; 1] Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
Am J Gastroenterol ; 109(6): 925-7, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24896764
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trato Gastrointestinal / Proteínas Adaptadoras de Transdução de Sinal / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Mercaptopurina / Metiltransferases Limite: Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trato Gastrointestinal / Proteínas Adaptadoras de Transdução de Sinal / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Mercaptopurina / Metiltransferases Limite: Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article